US Stock MarketDetailed Quotes
OSTX OS Therapies
- 2.000
- -0.050-2.44%
Close Nov 26 16:00 ET
42.48MMarket Cap-5714P/E (TTM)
2.060High1.946Low10.77KVolume2.020Open2.050Pre Close21.71KTurnover0.67%Turnover RatioLossP/E (Static)21.24MShares4.90052wk High-60.61P/B3.20MFloat Cap1.58052wk Low--Dividend TTM1.60MShs Float4.900Historical High--Div YieldTTM5.56%Amplitude1.580Historical Low2.015Avg Price1Lot Size
OS Therapies Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 291.73%2.44M | -48.54%779.8K | -39.87%630.23K | -2.33%4.34M | 1.16M | 622.21K | 1.52M | 17.84%1.05M | -8.08%4.45M | 889.39K |
| Selling and administrative expenses | 631.76%1.23M | -26.65%383.23K | -8.78%268.42K | -2.87%1.12M | --132.88K | --167.7K | --522.48K | 44.65%294.25K | -23.27%1.15M | --203.42K |
| -General and administrative expense | 631.76%1.23M | -26.65%383.23K | -8.78%268.42K | -2.87%1.12M | --132.88K | --167.7K | --522.48K | 44.65%294.25K | -23.27%1.15M | --203.42K |
| Research and development costs | 166.27%1.21M | -60.06%396.57K | -52.00%361.81K | -2.26%3.22M | --1.02M | --454.51K | --992.9K | 10.08%753.78K | 51.39%3.29M | --684.76K |
| Other operating expenses | ---- | ---- | ---- | 325.95%5.15K | ---- | ---- | ---- | ---- | -99.90%1.21K | --1.21K |
| Operating profit | -291.73%-2.44M | 48.54%-779.8K | 39.87%-630.23K | 2.33%-4.34M | -1.16M | -622.21K | -1.52M | -17.84%-1.05M | 8.08%-4.45M | -889.39K |
| Net non-operating interest income expense | 67.63%-437.84K | 21.42%-777.68K | -3.73%-828.76K | -90.72%-3.45M | -307.53K | -1.35M | -989.68K | -68.86%-798.94K | 29.99%-1.81M | -473.13K |
| Non-operating interest income | --0 | --1 | ---- | --2 | --0 | --1 | --0 | ---- | --0 | ---- |
| Non-operating interest expense | -67.63%437.84K | -21.42%777.68K | 3.73%828.76K | 90.72%3.45M | --307.53K | --1.35M | --989.68K | 68.86%798.94K | -29.99%1.81M | --473.13K |
| Other net income (expense) | ||||||||||
| Income before tax | -45.58%-2.88M | 37.83%-1.56M | 21.01%-1.46M | -24.57%-7.79M | -1.46M | -1.97M | -2.51M | -35.56%-1.85M | 15.71%-6.25M | -1.36M |
| Income tax | ||||||||||
| Net income | -45.58%-2.88M | 37.83%-1.56M | 21.01%-1.46M | -24.57%-7.79M | -1.46M | -1.97M | -2.51M | -35.56%-1.85M | 15.71%-6.25M | -1.36M |
| Net income continuous Operations | -45.58%-2.88M | 37.83%-1.56M | 21.01%-1.46M | -24.57%-7.79M | ---1.46M | ---1.97M | ---2.51M | -35.56%-1.85M | 15.71%-6.25M | ---1.36M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -45.58%-2.88M | 37.83%-1.56M | 21.01%-1.46M | -24.57%-7.79M | -1.46M | -1.97M | -2.51M | -35.56%-1.85M | 15.71%-6.25M | -1.36M |
| Preferred stock dividends | 0.00%31.25K | 0.00%125K | 31.25K | 31.25K | 31.25K | 0.00%31.25K | 33.33%125K | 31.25K | ||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -43.31%-2.88M | 38.59%-1.56M | 20.66%-1.49M | -24.09%-7.92M | -1.5M | -2.01M | -2.54M | -34.76%-1.88M | 15.10%-6.38M | -1.39M |
| Basic earnings per share | -79.88%-0.18 | 40.23%-0.0756 | 20.66%-0.0743 | -24.09%-0.3948 | -0.0726 | -0.1001 | -0.1265 | -56.33%-0.0937 | 2.18%-0.3182 | -0.0599 |
| Diluted earnings per share | -79.88%-0.18 | 40.23%-0.0756 | 20.66%-0.0743 | -24.09%-0.3948 | -0.0726 | -0.1001 | -0.1265 | -56.33%-0.0937 | 2.18%-0.3182 | -0.0599 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
